Publications The following includes a selection of recent publications from our lab. View the complete list here on PubMed.
Comparison of DBS lead targeting accuracy and procedure duration between 1.5- and 3-Tesla interventional MRI systems: an initial 12-month experience Southwell DG, Narvid JA, Martin AJ, Qasim SE, Starr PA, Larson PS Stereotact Funct Neurosurg. 2016; 94 (2): 102-7. [Epub 20 Apr 2016]. PubMed Link >
Delay period activity of the substantia nigra during proactive control of response selection as determined by a novel fMRI localization method Yoon JH, Larson P, Grandelis A, La C, Cui E, Carter CS, Minzenberg MJ J Cogn Neurosci. 2015; 27 (6): 1238-48. [Epub 16 Dec 2014]. PubMed Link >
Before and after the Veterans Affairs cooperative program 468 study: deep brain stimulator target selection for treatment of Parkinson’s disease Southwell DG, Rutkowski MJ, San Luciano M, Racine C, Ostrem J, Starr PA, Larson PS Parkinsonism Relat Disord. 2018; 48: 40-44. [Epub 12 Dec 2017]. PubMed Link >
DBS implantation in a diagnostic MR suite: infection history over a 10-year period Martin AJ, Larson PS, Ziman N, Levesque N, Ostrem JL, Starr PA. J Neurosurg. 2017; 126 (1): 108-113. [Epub 25 Mar 2016]. PubMed Link >
MRI-guided phase 1 trial of putaminal AADC gene therapy for Parkinson’s disease Christine C, Bankiewicz K, Van Laar A, Richardson R, Ravina B, Kells A, Brendon B, Martin A, Nutt J, Thompson M, Larson P Ann Neurol. 2019; Epub 25 Feb 2019. PubMed Link >
Hemorrhage detection and incidence during MR guided DBS implantation Marin AJ, Starr PA, Ostrem JL, Larson PS. Stereotact Funct Neurosurg. 2017; 95 (5): 307-314. [Epub 9 Sep 2017]. PubMed Link >
Long-term safety of patients with Parkinson’s disease receiving rAAV2-Neurturin (CERE-120) gene transfer Marks WJ Jr, Baumann TL, Bartus RT, CERE-120 Study Group Hum Gene Ther. 2016; 27 (7): 522-7. [Epub 24 Feb 2016]. PubMed Link >
Phase I Trial of Caudate Deep Brain Stimulation for Treatment-Resistant Tinnitus Cheung SW, Racine CA, Henderson-Sabes J, Demopoulos C, Molinaro AM, Heath S, Nagarajan SS, Bourne AL, Rietcheck JE, Wang SS, Larson PS. J Neurosurg. 2019 Sep 24; 1-10. doi: 10.3171/2019.4.JNS19347. Online ahead of print.. PubMed Link >
MRI-guided stereotactic neurosurgical procedures in a diagnostic MRI suite: background and safe practice recommendations Larson PS, Willie JT, Vadivelu S, Azmi-Ghadimi H, Nichols A, Litz-Faerbach L, Johnson HB J Healthc Risk Manag. 2017; 37 (1): 31-39. PubMed Link >
Merging DBS with viral vector or stem cell implantation: “hybrid” stereotactic surgery as an evolution in the surgical treatment of Parkinson’s disease Rowland NC, Kalia SK, Kalia LV, Larson PS, Lim DA, Bankiewicz KS Mol Ther Methods Clin Dev. 2016; 3: 15051 eCollection. [Epub 13 Jan 2016]. PubMed Link >
Human caudate nucleus subdivisions in tinnitus modulation Perez PL, Wang SS, Heath S, Henderson-Sabes J, Mizuiri D, Hinkley LB, Nagarajan SS, Larson PS, Cheung SW J Neurosurg. 2019 Feb 8; [Epub ahead of print]. PubMed Link >
Aromatic L-Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease Nutt JG, Curtze C, Hiller A, Anderson S, Larson PS, Van Laar AD, Richardson RM, Thompson ME, Sedkov A, Leinonen M, Ravina B, Bankiewicz KS, Christine CW. Mov Disord. 2020 May 1; 35 (5): 851-858. doi: 10.1002/mds.27993. Epub 2020 Mar 9. PubMed Link >
Little black boxes: Non-cardiac implantable electronic medical devices and their anesthetic and surgical implications Srejic U, Larson P, Bickler PE Anesth Analg. 2017; 125 (1): 124-128. PubMed Link >
Effective Interventional MRI-guided laser ablations in a Parkinson’s disease patient with refractory tremor San Luciano M, Katz M, Ostrem J, Martin A, Starr P, Ziman N, Larson P Mov Disord Clin Pract. 2015 Dec 14; 3 (3): 312-314. doi: 10.1002/mdc3.12283. eCollection 2016 May-Jun. PubMed Link >
Challenges and solutions for functional neurosurgery in developing countries Fezeu F, Ramesh A, Melmer PD, Moosa S, Larson PS, Henderson F Jr Cureus. 2018; 10 (9): e3314. PubMed Link >